How much does a box of ivonib (ivitinib) cost in China?

Ivonib, also known as ivitinib, is an isocitrate dehydrogenase1 inhibitor indicated for the treatment of acute myeloid leukemia and cholangiocarcinoma in adults who are susceptible to IDH1 mutations. It has been launched in China, but unfortunately, it has not yet been included in my country's medical insurance system. This means that patients need to bear the full cost to enjoy the therapeutic benefits of this drug. For many patients, this undoubtedly adds considerable financial pressure.

At present, the domestic market price of the Canadian imported version of Avonib is as high as 10 around 100,000 yuan, which is indeed a considerable expense for ordinary families. At the same time, there are other versions of avosidenib on the market for patients to choose from.

For example, the original research version in the United States has been recognized by patients for its research and development background and quality, but it is more expensive. The latest quotation is about 27 yuan. Such a price is undoubtedly a heavy burden for many patients who are in urgent need of medication.

It is worth mentioning that Laos also has a generic version of ivonib that is officially on the market-Lucius version. After rigorous testing, it was found that the ingredients of this generic drug are basically the same as those of the original American drug, but the price is very different. The latest price is only about 7,000 yuan. This undoubtedly provides patients with a more economical option.

But no matter which version the patient chooses, it is strongly recommended to purchase it through formal channels. There may be counterfeit and substandard drugs on the market, which not only fail to achieve therapeutic effects, but may also pose a greater threat to patients' health. Therefore, patients must be cautious when purchasing and ensure that the source of medicines is reliable to protect their own health and safety.